Supplementary Table S6 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Tumor recurrence following treatment is the major cause of mortality for glioblastoma multiforme (GBM) patients. Thus, insights on the evolutionary process at recurrence are critical for improved pati
The RNA-seq data of healthy tissue samples was analyzed to investigate tumor-specificity of fusion genes detected in RNA-seq data of unrelated tumor samples.
Table. GBM differentially expressed genes for Schulte et al. dataset [25]. The table reports the list of the statistically significant (adjusted p-value <0.05) DEGs in Official Gene Symbols identif
